Dolby Laboratories, Inc. (NYSE:DLB – Free Report) – William Blair upped their Q3 2025 earnings estimates for Dolby Laboratories in a note issued to investors on Wednesday, November 20th. William Blair analyst R. Schackart now anticipates that the electronics maker will post earnings of $0.52 per share for the quarter, up from their prior forecast of $0.43. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.
Several other equities analysts also recently commented on the company. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 18th. Rosenblatt Securities lifted their price objective on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 20th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a report on Wednesday, November 20th.
Dolby Laboratories Trading Up 0.4 %
NYSE DLB opened at $80.55 on Monday. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $90.06. The company has a market capitalization of $7.68 billion, a price-to-earnings ratio of 29.72 and a beta of 0.98. The stock’s 50 day moving average is $74.33 and its two-hundred day moving average is $75.98.
Institutional Trading of Dolby Laboratories
Hedge funds and other institutional investors have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD increased its stake in shares of Dolby Laboratories by 1.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 54,160 shares of the electronics maker’s stock valued at $4,538,000 after buying an additional 855 shares during the period. B. Riley Wealth Advisors Inc. increased its position in Dolby Laboratories by 41.4% in the first quarter. B. Riley Wealth Advisors Inc. now owns 5,363 shares of the electronics maker’s stock worth $425,000 after purchasing an additional 1,569 shares during the period. Tidal Investments LLC raised its holdings in Dolby Laboratories by 53.9% during the 1st quarter. Tidal Investments LLC now owns 10,493 shares of the electronics maker’s stock worth $879,000 after purchasing an additional 3,673 shares during the last quarter. LRI Investments LLC acquired a new position in Dolby Laboratories during the 1st quarter valued at about $178,000. Finally, Cetera Advisors LLC bought a new position in shares of Dolby Laboratories in the 1st quarter valued at about $225,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Insider Buying and Selling
In related news, Director Peter C. Gotcher sold 6,079 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the transaction, the director now owns 37,593 shares in the company, valued at $2,968,343.28. This represents a 13.92 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Yeaman sold 28,512 shares of the stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at approximately $6,205,400.52. This represents a 25.40 % decrease in their position. The disclosure for this sale can be found here. 39.54% of the stock is owned by corporate insiders.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd will be issued a $0.33 dividend. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a dividend yield of 1.64%. The ex-dividend date is Tuesday, December 3rd. Dolby Laboratories’s payout ratio is presently 44.28%.
Dolby Laboratories announced that its Board of Directors has approved a stock repurchase program on Wednesday, August 7th that allows the company to buyback $350.00 million in shares. This buyback authorization allows the electronics maker to buy up to 5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading
- Five stocks we like better than Dolby Laboratories
- What is the Hang Seng index?
- Disney’s Magic Strategy: Reinventing the House of Mouse
- 3 Tickers Leading a Meme Stock Revival
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- 3 Stocks to Consider Buying in October
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.